Skip to main content
SpringerLink
Log in

Fibromuscular Dysplasia: Renal

  • Chapter
  • First Online:
Endovascular Interventions

  • 270 Accesses

Abstract

Fibromuscular dysplasia (FMD) is a nonatherosclerotic, noninflammatory disease of medium-sized arteries characterized by abnormal cell growth leading to stenosis, occlusion, dissection, or aneurysm formation. It was first described in a 5-year-old child by Leadbetter in 1938; however, the first accurate pathologic description was set by McCormack and coworkers in 1958. Almost every artery can be involved, and in 26 % of patients, more than one arterial region is involved. It involves the renal arteries in 60–75 % of cases and is often bilateral, cerebrovascular arteries in 25–30 %, visceral arteries in 9 %, and less commonly in the carotid, iliac, or other vessels. The incidence of FMD is unknown; however, it is more common than previously thought.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Olin JW, Froehlich J, Gu X, et al. The United States registry for fibromuscular dysplasia: results in the first 447 patients. Circulation. 2012;125(25):3182–90.

    Article  PubMed  Google Scholar 

  2. Leadbetter WF, Burkland CE. Hypertension in unilateral renal disease. J Urol. 1938;39:611–26.

    Google Scholar 

  3. McCormack IJ, Hazard JB, Poutasse EF. Obstructive lesions of the renal artery associated with remediable hypertension. Am J Pathol. 1958;34:582 (abstract).

    Google Scholar 

  4. De Bray JM, Marc G, Pautot V, Vielle B, Pasco A, Lhoste P. Fibromuscular dysplasia may herald symptomatic recurrence of cervical artery dissection. Cerebrovasc Dis. 2007;23(5–6):448–52.

    Article  PubMed  Google Scholar 

  5. Luscher TF, Lie JT, Stanson AW, et al. Arterial fibromuscular dysplasia. Mayo Clin Proc. 1987;62(10):931–52.

    Article  PubMed  CAS  Google Scholar 

  6. Olin JW, Sealove BA. Diagnosis, management, and future developments of fibromuscular dysplasia. J Vasc Surg. 2011;53(3):826–36. e1.

    Article  PubMed  Google Scholar 

  7. Poloskey SL, Olin JW, Mace P, Gornik HL. Fibromuscular dysplasia. Circulation. 2012;125:e636–9.

    Article  PubMed  Google Scholar 

  8. Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med. 2004;350:1862–71.

    Article  PubMed  CAS  Google Scholar 

  9. Begelman SM, Olin JW. Fibromuscular dysplasia. Curr Opin Rheumatol. 2000;12:41–7.

    Article  PubMed  CAS  Google Scholar 

  10. Kincaid OW, Davis GD, Hallermann FJ, Hunt JC. Fibromuscular dysplasia of renal the arteries: arteriographic features, classification, and observations on natural history of disease. Am J Roentgenol Radium Ther Nucl Med. 1968;104:271–82.

    Article  PubMed  CAS  Google Scholar 

  11. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am. 1984;11:383–92.

    PubMed  CAS  Google Scholar 

  12. Goncharenko V, Gerlock Jr AJ, Shafff MI, Hollifield JW. Progression of renal artery fibromuscular dysplasia in 42 patients as seen on angiography. Radiology. 1981;139:45–51.

    PubMed  CAS  Google Scholar 

  13. Colyer Jr WR, Cooper CJ. Management of renal artery stenosis: 2010. Curr Treat Options Cardiovasc Med. 2011;13(2):103–13.

    Article  PubMed  Google Scholar 

  14. Carman TL, Olin JW, Czum J. Noninvasive imaging of renal arteries. Urol Clin North Am. 2001;28:815–26.

    Article  PubMed  CAS  Google Scholar 

  15. Zeller T, Rastan A, Noory E. Renal artery intervention – endovascular technique. Vasc Dis Manag. 2011;8:E21–7.

    Google Scholar 

  16. Prasad A, Zafar N, Mahmud E. Assessment of renal artery fibromuscular dysplasia: angiography, intravascular ultrasound (with virtual histology), and pressure wire measurements. Catheter Cardiovasc Interv. 2009;74:260–4.

    PubMed  Google Scholar 

  17. Feldman RL, Wargovich TJ, Bittl JA. No-touch technique for reducing aortic wall trauma during renal artery stenting. Catheter Cardiovasc Interv. 1999;46:245–8.

    Article  PubMed  CAS  Google Scholar 

  18. Cluzel P, Raynaud A, Beyssen B, Pagny JY, Gaux JC. Stenoses of renal branch arteries in fibromuscular dysplasia: results of percutaneous transluminal angioplasty. Radiology. 1994;193:227–32.

    PubMed  CAS  Google Scholar 

  19. Birrer M, Do DD, Mahler F, Triller J, Baumgartner I. Treatment of renal artery fibromuscular dysplasia with balloon angioplasty: a prospective follow-up study. Eur J Vasc Endovasc Surg. 2002;23:146–52.

    Article  PubMed  CAS  Google Scholar 

  20. Gowda MS, Loeb AL, Crouse IJ, Kramer PH. Complementary roles of color flow duplex imaging and intravascular ultrasound in the diagnosis of renal artery fibromuscular dysplasia: should renal angiography serve as gold standard? J Am Coll Cardiol. 2003;41:1305–11.

    Article  PubMed  Google Scholar 

  21. Airoldi F, Palatresi S, Marana I, et al. Angioplasty of atherosclerotic and fibromuscular renal artery stenosis: time course and predicting factors of the effects on renal function. Am J Hypertens. 2000;13:1210–7.

    Article  PubMed  CAS  Google Scholar 

  22. De Fraissinette B, Garcier JM, Dieu V, et al. Percutaneous transluminal angioplasty of dysplastic stenoses of the renal artery: results on 70 adults. Cardiovasc Intervent Radiol. 2003;26:46–51.

    Article  PubMed  Google Scholar 

  23. Davies MG, Saad WE, Peden EK, et al. The long term outcomes for percutaneous therapy for renal artery fibromuscular dysplasia. J Vasc Surg. 2008;48:865–71.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Division of Cardiovascular Medicine, Department of Medicine, University of Toledo, 3000 Arlington Avenue, 1118, Toledo, OH, USA

    Mohammed Taleb MD & Christopher J. Cooper MD

  2. Department of Cardiology, University of Toledo Medical Center, 3000 Arlington Avenue, Toledo, OH, 43614, USA

    Mohammed Taleb MD

Authors
  1. Mohammed Taleb MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher J. Cooper MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Edward Hines, Jr. VA Hospital Loyola University Medical Center, Glen Ellyn, Illinois, USA

    Robert S. Dieter

  2. Northern Illinois Surgery Center, Naperville, Illinois, USA

    Raymond A. Dieter, Jr.

  3. University of Tennessee Medical Center, Knoxville, Tennessee, USA

    Raymond A. Dieter, III

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Taleb, M., Cooper, C.J. (2014). Fibromuscular Dysplasia: Renal. In: Dieter, R., Dieter, Jr., R., Dieter, III, R. (eds) Endovascular Interventions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7312-1_35

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7312-1_35

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-7311-4

  • Online ISBN: 978-1-4614-7312-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation